Endpoints for clinical trials on treatment of hepatitis C

被引：2

作者：

Kang, Hellan ^{[1
]}

Lok, Anna S. F. ^{[1
]}

机构：

[1] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF HEPATOLOGY | 2006年 / 45卷 / 04期

关键词：

D O I：

10.1016/j.jhep.2006.07.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：473 / 475

页数：3

共 50 条

[41] Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment
Quan, H
Luo, XH
Capizzi, T
STATISTICS IN MEDICINE, 2005, 24 (14) : 2151 - 2170
[42] Treatment endpoints for chronic hepatitis D
Metin, Olga
Zeybel, Mujdat
Yurdaydin, Cihan
LIVER INTERNATIONAL, 2023, 43 : 60 - 68
[43] The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases
Lonn, E
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) : 497 - 508
[44] Design and Endpoints of Clinical Trials, Current and Future
Sherman, Morris
DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (04) : 1050 - 1057
[45] Novel Endpoints for Heart Failure Clinical Trials
Hamo C.E.
Gheorghiade M.
Butler J.
Current Heart Failure Reports, 2017, 14 (4) : 210 - 216
[46] Endpoints for Clinical Trials of Acute Kidney Injury
Palevsky, Paul M.
NEPHRON, 2018, 140 (02) : 111 - 115
[47] Selection of composite binary endpoints in clinical trials
Bofill Roig, Marta
Gomez Melis, Guadalupe
BIOMETRICAL JOURNAL, 2018, 60 (02) : 246 - 261
[48] How to deal with multiple endpoints in clinical trials
Neuhaeuser, Markus
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (06) : 515 - 523
[49] Clinical trials: design, endpoints and interpretation of outcomes
Megan Othus
Mei-Jie Zhang
Robert Peter Gale
Bone Marrow Transplantation, 2022, 57 : 338 - 342
[50] Appropriate Endpoints for Renal Transplantation Clinical Trials
Claudio Ponticelli
Mariarosaria Campise
Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 207 - 212

← 1 2 3 4 5 →